Dosage-dependent regulation of <i>VAV2</i> expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasion
Carmen Ruggiero(Centre National de la Recherche Scientifique), Enzo Lalli(Centre National de la Recherche Scientifique), Iuliu Sbiera, Martin Faßnacht(University of Würzburg), Judith Favier(Inserm), Estelle Robidel(Délégation Paris 5), Maddy Parsons(King's College London), Mabrouka Doghman(Centre National de la Recherche Scientifique), Aurélie Morin(Centre National de la Recherche Scientifique), Bruno Ragazzon(Centre National de la Recherche Scientifique), Silviu Sbiera(University of Würzburg), Jérôme Bertherat(Centre National de la Recherche Scientifique)
Cited by 38
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
The ratio of the nucleon structure functions F2N for iron and deuterium
|Physics Letters B|1983|1.1k
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2018|927
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772